Capsule size of Cryptococcus neoformans: control and relationship to virulence.
about
The Cryptococcus neoformans capsule: a sword and a shield.Experimental modulation of capsule size in Cryptococcus neoformansCryptococcus neoformans Intracellular Proliferation and Capsule Size Determines Early Macrophage Control of Infection.Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformansCryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cationsAccumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes.Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans.Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrationsG protein-coupled receptor Gpr4 senses amino acids and activates the cAMP-PKA pathway in Cryptococcus neoformans.Pathogenesis, lethality, and immunizing effect of experimental cutaneous cryptococcosisPathogenesis of pulmonary Cryptococcus neoformans infection in the ratVirulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxideEvidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity.The STE12alpha homolog is required for haploid filamentation but largely dispensable for mating and virulence in Cryptococcus neoformans.A genetic linkage map of Cryptococcus neoformans variety neoformans serotype D (Filobasidiella neoformans).Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated formCapsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival.Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans.Does the Capsule Interfere with Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Cryptococcus neoformans and Cryptococcus gattii?Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2).Immunization of mice by intracutaneous inoculation with viable virulent Cryptococcus neoformans: immunological and histopathological parameters.Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. The Cryplococcal Disease Active Surveillance GroupEncapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responsesStrain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype AStrain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A.Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans.Multilocus enzyme typing of Cryptococcus neoformans.The capsule of the fungal pathogen Cryptococcus neoformans.The Cryptococcus neoformans Rim101 transcription factor directly regulates genes required for adaptation to the host.Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines.Identification of N-acetylneuraminic acid and its 9-O-acetylated derivative on the cell surface of Cryptococcus neoformans: influence on fungal phagocytosis.Serotyping Cryptococcus neoformans by immunofluorescence.Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans.Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens.Role for chitin and chitooligomers in the capsular architecture of Cryptococcus neoformans.The still obscure attributes of cryptococcal glucuronoxylomannan.Nutritional Requirements and Their Importance for Virulence of Pathogenic Cryptococcus Species.Fungal Strategies to Evade the Host Immune Recognition.
P2860
Q24619875-0DAD76B1-26FF-4E45-8983-882C60FEB5B9Q24805267-6E2C429C-CEAF-4BDA-B80C-CE860738FED8Q27347238-25590CA5-D47B-45C4-B5F7-9EE8A98BFEACQ28343929-08BDAF49-891B-4253-9066-283EC1F6BFD2Q30424017-84B4D377-AEE8-4BD0-AC55-EED906941ED1Q30479935-456077FB-FE15-4708-9F3D-109194C944A8Q33705456-CA510D37-DDD9-4E90-853F-85EAC4DA6F38Q33790656-6630527B-346C-4A12-8350-DFA4B53D937AQ33913191-257FA863-1A0E-4E03-B5A7-C2F7405F25C3Q33975989-C8582E69-F516-4513-956C-78D2D7224106Q34325690-6AD00218-632E-43A6-9FB6-B69EE2053868Q34445453-003A075C-50C5-4AC9-A2D2-A2DEAEEED392Q34543565-195CE1E1-13A6-4A72-82A3-62536211F3A5Q34547882-8AD22618-3E6C-4288-8EB2-56B237E73042Q34561087-E1051370-50B2-42C4-93F4-4730963CABD5Q34608349-4F453193-F7F8-4B88-BDDF-AE556E4B24E8Q34645137-83DDE8E4-3665-4EFF-9BEE-4161C8D8F110Q35422948-DAA63A26-3F8F-4A49-94C3-825C80588E8AQ35512999-C39011C8-5E96-47FE-8FEB-28F7E6E604C7Q35556339-E22DEABC-727A-45C6-A0F1-1112BCFA7957Q35867195-82C90AC4-758C-4B68-BE8C-3A6B43D5474CQ36376167-BBE26166-85E7-423C-AF88-2E3805858FF8Q36436493-2CDA0690-045D-4C55-ABB7-6DF22FF5F387Q36523409-3058115A-30CB-49F6-A81F-D5628FA89693Q36988622-B7ED64DA-F3AE-420A-9269-30CF59A1E6DCQ37006902-059A05B9-96E5-487B-BBD9-F1D0D7DEAFEAQ37013950-4F894E91-8AE1-4DC8-953E-4D3CD7FD42E1Q37030704-6C1A6845-6FF9-43A2-9A88-122C16F0C8A0Q37139073-F369366A-1244-4FD5-A58E-4A36A59C37A5Q37337879-376325A1-8DD6-4C78-B321-908FA66BEB70Q37546870-7667CCAC-A898-47DB-833F-5125C74E6738Q39522424-F5BC50C5-0F28-4C92-B14B-BF501D4A2D4AQ39831643-98C2FDB9-2D2C-4B98-9BFB-8B193E902022Q40222442-C5E4737F-3529-4ABF-AF9E-26A38ED4A7A7Q40373891-1D7D2662-EBA3-4258-AC07-9660B9597986Q40771289-E2A5A093-D3B5-4C6E-B721-2483C2634BACQ42017970-1F45FC4E-63DE-45A7-8B32-FDEFEC29EAA9Q43134636-C75C3413-3787-4BA1-B651-2B709AAC3965Q46295778-390CAF03-536A-4BB3-A68A-4B5DC6D10129Q48163110-4BA960E3-8BD1-4CD2-8DEF-E435E6AC28DD
P2860
Capsule size of Cryptococcus neoformans: control and relationship to virulence.
description
1977 nî lūn-bûn
@nan
1977 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Capsule size of Cryptococcus neoformans: control and relationship to virulence.
@ast
Capsule size of Cryptococcus neoformans: control and relationship to virulence.
@en
Capsule size of Cryptococcus neoformans: control and relationship to virulence.
@nl
type
label
Capsule size of Cryptococcus neoformans: control and relationship to virulence.
@ast
Capsule size of Cryptococcus neoformans: control and relationship to virulence.
@en
Capsule size of Cryptococcus neoformans: control and relationship to virulence.
@nl
prefLabel
Capsule size of Cryptococcus neoformans: control and relationship to virulence.
@ast
Capsule size of Cryptococcus neoformans: control and relationship to virulence.
@en
Capsule size of Cryptococcus neoformans: control and relationship to virulence.
@nl
P2093
P2860
P1476
Capsule size of Cryptococcus neoformans: control and relationship to virulence.
@en
P2093
P2860
P304
P407
P577
1977-04-01T00:00:00Z